4.6 Article

S-Adenosyl Methionine and Transmethylation Pathways in Neuropsychiatric Diseases Throughout Life

期刊

NEUROTHERAPEUTICS
卷 15, 期 1, 页码 156-175

出版社

SPRINGER
DOI: 10.1007/s13311-017-0593-0

关键词

S-Adenosyl-methionine; Transmethylation; Pathway; Psychiatric disease; Neurodegenerative disease

资金

  1. National Natural Science Foundation of China [81501170]
  2. Zenith Fellows Award of Alzheimer's Association
  3. National Institutes of Health [R21NS077079-01A1, 1R01AG056614-01]
  4. [5R01MH102279-03]
  5. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS077079, R21NS059434, R21NS064853] Funding Source: NIH RePORTER
  6. NATIONAL INSTITUTE ON AGING [R01AG056614] Funding Source: NIH RePORTER

向作者/读者索取更多资源

S-Adenosyl methionine (SAMe), as a major methyl donor, exerts its influence on central nervous system function through cellular transmethylation pathways, including the methylation of DNA, histones, protein phosphatase 2A, and several catecholamine moieties. Based on available evidence, this review focuses on the lifelong range of severe neuropsychiatric and neurodegenerative diseases and their associated neuropathologies, which have been linked to the deficiency/load of SAMe production or/and the disturbance in transmethylation pathways. Also included in this review are the present-day applications of SAMe in the treatment in these diseases in each age group.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据